Other news reports today — from sources not related to the ASTRO annual meeting — address such topics as:
- Perceptions about the US Preventive Services Task Force recommendations regarding the use of PSA testing men men > 75 years
- Renal insufficiency in men of long-term drug therapy for prostate cancer
- Cetuximab + doxirubicin in the treatment of CRPC
- The mechanism of action of estrogens in treatment of advanced prostate cancer … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: cetruximab, doxirubicin, estrogen, PSA testing, renal in sufficiency, USPSTF | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 